Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
0.600
+0.011 (1.94%)
At close: May 24, 2024, 3:59 PM
0.598
-0.002 (-0.35%)
After-hours: May 24, 2024, 6:12 PM EDT

Alzamend Neuro Income Statement

Millions USD. Fiscal year is May - Apr.
Year 20232022202120202019
Selling, General & Admin
7.427.123.643.351.31
Research & Development
7.455.21.311.073.7
Operating Expenses
14.8712.324.954.425.01
Operating Income
-14.87-12.32-4.95-4.42-5.01
Interest Expense / Income
0.010.050.1600
Other Expense / Income
--0-0.06-0.01-0.15
Pretax Income
-14.88-12.36-5.05-4.41-4.86
Net Income
-14.88-12.36-5.05-4.41-4.86
Shares Outstanding (Basic)
76554
Shares Outstanding (Diluted)
76554
Shares Change
9.45%22.64%1.96%21.09%-
EPS (Basic)
-2.25-2.10-1.05-0.90-1.20
EPS (Diluted)
-2.25-2.10-1.05-0.90-1.20
Free Cash Flow
-8.92-6.72-2.71-2.35-1.05
Free Cash Flow Per Share
-1.37-1.13-0.56-0.49-0.27
EBITDA
-14.85-12.31-4.89-4.41-4.86
Depreciation & Amortization
0.020000
EBIT
-14.87-12.32-4.89-4.41-4.86
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).